3-Phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride, 250mg

1-Ethyl-1-methylpyrrolidinium Tetrafluoroborate, 97%, 25g

3-(2,6-Difluorophenyl)-3-oxopropanenitrile, 95.0%, 1g

2-Bromo-3-fluoro-5-methoxypyridine, 97%, 250mg

6-Methylpyridine-2(1H)-thione>98.0%(HPLC)(T)1g

{[2-(benzyloxy)phenyl]methyl}(propan-2-yl)amine, 95.0%, 2g

2,3,4-Trifluoro-5-(trifluoromethyl)aniline, 1g

(2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone, 95.0%, 100g

BENZYL N-{[4-(IODOMETHYL)-2-OXABICYCLO[2.1.1]HEXAN-1-YL]METHYLCARBAMATE, 95%, 1g

n-Butyl 2,2-difluorocyclopropanecarboxylate, 95.0%, 250mg

1-(3-BROMOPHENYL)-4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 95.0%, 1g

Ginsenoside-Rg1, estándar de trabajo ROTICHROM®, 25 mg, envase de vidrio

tert-Butyl 3-(3-amino-1H-pyrazol-1-yl)azetidine-1-carboxylate, 98%, 10g